Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caterina Labanca

Showing results (1-10 of 54) with videos related to

Pageof 6
Sort By:
European Journal of Haematology|October 17, 2023
Teclistamab-cqyv in multiple myelomaEnrica Antonia Martino, Antonella Bruzzese, Caterina Labanca, et al.
European Journal of Haematology|June 23, 2025
Treatment-Free Remission in Chronic Myeloid Leukemia: Revisiting the "W" QuestionsAntonella Bruzzese, Ernesto Vigna, Enrica Antonia Martino, et al.
European Journal of Haematology|October 8, 2025
Herpes Zoster in Hematological Disorders: Pathogenesis, Risk Stratification, and Emerging Strategies for Prevention and ImmunizationEnrica Antonia Martino, Ernesto Vigna, Antonella Bruzzese, et al.
Expert Opinion on Pharmacotherapy|October 24, 2023
Ivosidenib in acute myeloid leukemiaAntonella Bruzzese, Caterina Labanca, Enrica Antonia Martino, et al.
European Journal of Haematology|July 27, 2025
Vaccination in Multiple Myeloma: Challenges and StrategiesEnrica Antonia Martino, Ernesto Vigna, Antonella Bruzzese, et al.
Expert Opinion on Pharmacotherapy|October 10, 2024
The role of corticosteroids in the current treatment paradigm for myelofibrosisAntonella Bruzzese, Enrica Antonia Martino, Caterina Labanca, et al.
European Journal of Haematology|November 26, 2025
Infections in Chronic Lymphocytic Leukemia: Evolving Risks and Prevention StrategiesEnrica Antonia Martino, Santino Caserta, Ernesto Vigna, et al.
European Journal of Haematology|September 13, 2025
Bruton Tyrosine Kinase Inhibitors in Mantle Cell Lymphoma: What Are the Current Options?Santino Caserta, Enrica Antonia Martino, Ernesto Vigna, et al.
Expert Opinion on Pharmacotherapy|July 1, 2023
Glasdegib for the treatment of acute myeloid leukemiaAntonella Bruzzese, Enrica Antonia Martino, Caterina Labanca, et al.
European Journal of Haematology|November 9, 2025
T-Cell-Redirecting Immunotherapies in Relapsed/Refractory Mantle Cell Lymphoma: Current Evidence, Sequencing, and Future DirectionsSantino Caserta, Enrica Antonia Martino, Ernesto Vigna, et al.
Pageof 6

Showing results (1-10 of 54) with videos related to

Sort By:
Pageof 6
European Journal of Haematology|October 17, 2023
Teclistamab-cqyv in multiple myelomaEnrica Antonia Martino, Antonella Bruzzese, Caterina Labanca, et al.
European Journal of Haematology|June 23, 2025
Treatment-Free Remission in Chronic Myeloid Leukemia: Revisiting the "W" QuestionsAntonella Bruzzese, Ernesto Vigna, Enrica Antonia Martino, et al.
European Journal of Haematology|October 8, 2025
Herpes Zoster in Hematological Disorders: Pathogenesis, Risk Stratification, and Emerging Strategies for Prevention and ImmunizationEnrica Antonia Martino, Ernesto Vigna, Antonella Bruzzese, et al.
Expert Opinion on Pharmacotherapy|October 24, 2023
Ivosidenib in acute myeloid leukemiaAntonella Bruzzese, Caterina Labanca, Enrica Antonia Martino, et al.
European Journal of Haematology|July 27, 2025
Vaccination in Multiple Myeloma: Challenges and StrategiesEnrica Antonia Martino, Ernesto Vigna, Antonella Bruzzese, et al.
Expert Opinion on Pharmacotherapy|October 10, 2024
The role of corticosteroids in the current treatment paradigm for myelofibrosisAntonella Bruzzese, Enrica Antonia Martino, Caterina Labanca, et al.
European Journal of Haematology|November 26, 2025
Infections in Chronic Lymphocytic Leukemia: Evolving Risks and Prevention StrategiesEnrica Antonia Martino, Santino Caserta, Ernesto Vigna, et al.
European Journal of Haematology|September 13, 2025
Bruton Tyrosine Kinase Inhibitors in Mantle Cell Lymphoma: What Are the Current Options?Santino Caserta, Enrica Antonia Martino, Ernesto Vigna, et al.
Expert Opinion on Pharmacotherapy|July 1, 2023
Glasdegib for the treatment of acute myeloid leukemiaAntonella Bruzzese, Enrica Antonia Martino, Caterina Labanca, et al.
European Journal of Haematology|November 9, 2025
T-Cell-Redirecting Immunotherapies in Relapsed/Refractory Mantle Cell Lymphoma: Current Evidence, Sequencing, and Future DirectionsSantino Caserta, Enrica Antonia Martino, Ernesto Vigna, et al.
Pageof 6